A common variant in ERBB4 regulates gaba concentrations in human cerebrospinal fluid

Neuropsychopharmacology

Volumn 37, Issue 9, 2012, Pages 2088-2092

  Luykx, Jurjen J ^a   Vinkers, Christiaan H ^a,b   Bakker, Steven C ^a   Visser, Wouter F ^c   Van Boxmeer, Loes ^a   Strengman, Eric ^d,e   Van Eijk, Kristel R ^d   Lens, Judith A ^f   Borgdorff, Paul ^f   Keijzers, Peter ^g   Kappen, Teus H ^d   Van Dongen, Eric P A ^h   Bruins, Peter ^h   Verhoeven, Nanda M ^c   De Koning, Tom J ^c,i   Kahn, René S ^a   Ophoff, Roel A ^a,e  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f DEPARTMENT OF SURGERY   (Netherlands)

^g CENTRAL MILITARY HOSPITAL   (Netherlands)

^h ST ANTONIUS HOSPITAL   (Netherlands)

ⁱ UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

cerebrospinal fluid; ErbB4; GABA; neuregulin; rs7598440; schizophrenia

Indexed keywords

4 AMINOBUTYRIC ACID; EPIDERMAL GROWTH FACTOR RECEPTOR 4;

ADULT; ALLELE; ARTICLE; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; FEMALE; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC LINKAGE; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; HUMAN; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; CENTRAL NERVOUS SYSTEM; FEMALE; GAMMA-AMINOBUTYRIC ACID; GENETIC VARIATION; HUMANS; MALE; MIDDLE AGED; MODELS, GENETIC; RECEPTOR, EPIDERMAL GROWTH FACTOR; YOUNG ADULT;

EID: 84863988697     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2012.57     Document Type: Article

References (24)

1. Barnard EA, Skolnick P, Olsen RW, Mohler H, Sieghart W, Biggio G et al (1998). International Union of Pharmacology. XV. Subtypes of gamma-aminobutyric acidA receptors: classification on the basis of subunit structure and receptor function. Pharmacol Rev 50: 291-313.
2. Bohlen P, Huot S, Palfreyman MG (1979). The relationship between GABA concentrations in brain and cerebrospinal fluid. Brain Res 167: 297-305.
3. Chen YJ, Zhang M, Yin DM, Wen L, Ting A, Wang P et al (2011). ErbB4 in parvalbumin-positive interneurons is critical for neuregulin 1 regulation of long-term potentiation. Proc Natl Acad Sci USA 107: 21818-21823.
4. Epperson CN, O'Malley S, Czarkowski KA, Gueorguieva R, Jatlow P, Sanacora G et al (2005). Sex, GABA, and nicotine: the impact of smoking on cortical GABA levels across the menstrual cycle as measured with proton magnetic resonance spectroscopy. Biol Psychiatry 57: 44-48.
5. Fazzari P, Paternain AV, Valiente M, Pla R, Lujan R, Lloyd K et al (2010). Control of cortical GABA circuitry development by Nrg1 and ErbB4 signalling. Nature 464: 1376-1380.
6. Grove J, Palfreyman MG, Schechter PJ (1983). Cerebrospinal fluid GABA as an index of brain GABA activity. Clin Neuropharmacol 6: 223-229.
7. Grove J, Schechter PJ, Hanke NF, de Smet Y, Agid Y, Tell G et al (1982). Concentration gradients of free and total gammaaminobutyric acid and homocarnosine in human CSF: comparison of suboccipital and lumbar sampling. J Neurochem 39: 1618-1622.
8. Hahn CG, Wang HY, Cho DS, Talbot K, Gur RE, Berrettini WH et al (2006). Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia. Nat Med 12: 824-828.
9. Hare TA (1981). Alterations of central GABAergic activity in neurologic and psychiatric disorders: evaluation through measurements of GABA and GAD activity in cerebrospinal fluid. Mol Cell Biochem 39: 297-304.
10. Hull J, Campino S, Rowlands K, Chan MS, Copley RR, Taylor MS et al (2007). Identification of common genetic variation that modulates alternative splicing. PLoS Genet 3: e99.
11. Jaaro-Peled H, Hayashi-Takagi A, Seshadri S, Kamiya A, Brandon NJ, Sawa A (2009). Neurodevelopmental mechanisms of schizophrenia: understanding disturbed postnatal brain maturation through neuregulin-1-ErbB4 and DISC1. Trends Neurosci 32: 485-495.
12. Kwon OB, Paredes D, Gonzalez CM, Neddens J, Hernandez L, Vullhorst D et al (2008). Neuregulin-1 regulates LTP at CA1 hippocampal synapses through activation of dopamine D4 receptors. Proc Natl Acad Sci USA 105: 15587-15592.
13. Law AJ, Kleinman JE, Weinberger DR, Weickert CS (2007). Disease-associated intronic variants in the ErbB4 gene are related to altered ErbB4 splice-variant expression in the brain in schizophrenia. Hum Mol Genet 16: 129-141.
14. Li D, Collier DA, He L (2006). Meta-analysis shows strong positive association of the neuregulin 1 (NRG1) gene with schizophrenia. Hum Mol Genet 15: 1995-2002.
15. Manyam BV, Hare TA (1983). Cerebrospinal fluid GABA measurements: basic and clinical considerations. Clin Neuropharmacol 6: 25-36.
16. Marenco S, Geramita M, van der Veen JW, Barnett AS, Kolachana B, Shen J et al (2011). Genetic association of ErbB4 and human cortical GABA levels in vivo. J Neurosci 31: 11628-11632.
17. Mei L, Xiong WC (2008). Neuregulin 1 in neural development, synaptic plasticity and schizophrenia. Nat Rev Neurosci 9: 437-452.
18. Neddens J, Fish KN, Tricoire L, Vullhorst D, Shamir A, Chung W et al (2011). Conserved interneuron-specific ErbB4 expression in frontal cortex of rodents, monkeys, and humans: implications for schizophrenia. Biol Psychiatry 70: 636-645.
19. Sauna ZE, Kimchi-Sarfaty C (2011). Understanding the contribution of synonymous mutations to human disease. Nat Rev Genet 12: 683-691.
20. Spielberger C (1989). State-Trait Anxiety Inventory:v A Comprehensive Bibliography. Consulting Psychologists Press: Palo Alto.
21. Visser WF, Verhoeven-Duif NM, Ophoff R, Bakker S, Klomp LW, Berger R et al (2011). A sensitive and simple ultra-highperformance-liquid chromatography-tandem mass spectrometry based method for the quantification of D-amino acids in body fluids. J Chromatogr A 1218: 7130-7136.
22. Walsh T, McClellan JM, McCarthy SE, Addington AM, Pierce SB, Cooper GM et al (2008). Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science 320: 539-543.
23. Wen L, Lu YS, Zhu XH, Li XM, Woo RS, Chen YJ et al (2010). Neuregulin 1 regulates pyramidal neuron activity via ErbB4 in parvalbumin-positive interneurons. Proc Natl Acad Sci USA 107: 1211-1216.
24. Woo RS, Li XM, Tao Y, Carpenter-Hyland E, Huang YZ, Weber J et al (2007). Neuregulin-1 enhances depolarization-induced GABA release. Neuron 54: 599-610.